Copper‐Based Composites Nanoparticles Improve Triple‐Negative Breast Cancer Treatment with Induction of Apoptosis‐Cuproptosis and Immune Activation
Advanced Healthcare Materials · 2024-11 · 13 (28)
DOI: 10.1002/adhm.202401646 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 12.07.2024. Verfasst von Ning Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Dalian Medical University, Dalian, 116044, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Copper, Apoptosis, Doxorubicin. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Liaoning Provincial Department of Education, Doctoral Start-up Foundation of Liaoning Province.
Abstract (Originalsprache)
The synergistic effect of apoptosis and cuproptosis, along with the activation of the immune system, presents a promising approach to enhance the efficacy against triple‐negative breast cancer (TNBC). Here, two prodrugs are synthesized: a reactive oxygen species (ROS)‐responsive prodrug PEG‐TK‐DOX and a glutathione (GSH)‐responsive prodrug PEG‐DTPA‐SS‐CPT. These prodrugs are self‐assembled and chelated Cu 2+ to prepare nanoparticle PCD@Cu that simultaneously loaded doxorubicin (DOX), camptothecin (CPT), and Cu 2+ . The elevated levels of ROS and GSH in TNBC cells disrupted the PCD@Cu structure, leading to the release of Cu + , DOX, and CPT and the depletion of GSH. DOX and CPT triggered apoptosis with immunogenic cell death (ICD) in TNBC cells. Simultaneously, PCD@Cu downregulated the expression of copper transporting ATPase 2 (ATP7B), causing a significant accumulation of copper ions in TNBC cells. This further induced the aggregation of lipoylated dihydrolipoamide S‐acetyltransferase (DLAT) and downregulation of iron‐sulfur (Fe‐S) cluster proteins, ultimately leading to cuproptosis and ICD in TNBC. In vitro and in vivo experiments confirmed that PCD@Cu induced apoptosis and cuproptosis in TNBC and activated the immune system, demonstrating strong anti‐tumor capabilities. Moreover, PCD@Cu exhibited an excellent biosafety profile. Overall, this study provides a promising strategy for effective TNBC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Dalian Medical University, Dalian, 116044, China.
- School of Materials Science and Engineering, Jilin University, Changchun, 130012, China.
- Department of Nuclear Medicine, the First Affiliated Hospital of Dalian Medical University, Dalian, 116021, China.
- College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, 430065, China.
- Hubei Shizhen Laboratory, Wuhan, 430065, China.
ORCID-Profile: Jinyong Peng
Förderung
- Liaoning Provincial Department of Education
- Doctoral Start-up Foundation of Liaoning Province
Zitieren
APA
Wang, N., Liu, Y., Peng, D., Zhang, Q., Zhang, Z., Xu, L., Yin, L., Zhao, X., Lu, Z., & Peng, J. (2024). Copper‐Based Composites Nanoparticles Improve Triple‐Negative Breast Cancer Treatment with Induction of Apoptosis‐Cuproptosis and Immune Activation. Advanced Healthcare Materials, 13(28). https://doi.org/10.1002/adhm.202401646
Vancouver
Wang N, Liu Y, Peng D, Zhang Q, Zhang Z, Xu L, et al. Copper‐Based Composites Nanoparticles Improve Triple‐Negative Breast Cancer Treatment with Induction of Apoptosis‐Cuproptosis and Immune Activation. Advanced Healthcare Materials. 2024;13(28). doi:10.1002/adhm.202401646
BibTeX
@article{Wang2024,
author = {Wang, Ning and Liu, Yichao and Peng, Dezhou and Zhang, Qiyu and Zhang, Zhibo and Xu, Lina and Yin, Lianhong and Zhao, Xuerong and Lu, Zhi and Peng, Jinyong},
title = {Copper‐Based Composites Nanoparticles Improve Triple‐Negative Breast Cancer Treatment with Induction of Apoptosis‐Cuproptosis and Immune Activation},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {28},
doi = {10.1002/adhm.202401646}
}
EUVIMED